Skip to main content
SpringerLink
Log in
Book cover

Cancer Policy: Pharmaceutical Safety pp 119–128Cite as

Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos

  • Chapter
  • First Online:

Part of the book series: Cancer Treatment and Research ((CTAR,volume 171))

Abstract

Funded by the 21st Century Cures Act, The Beau Biden Cancer Moonshot Initiative is broad, deep, integrative, and intended to expediently address cancer’s most vexing problems. Launched in 2015, it is an effort to accelerate the pace of cancer research with a focus on breaking down silos through cross-pollination of research, recruitment of multidisciplinary clinical and basic science research teams, sharing of complex scientific databases, and the creation of public-private research partnerships. This audacious approach to cancer treatment is intended to alleviate the current burden of cancer within countries and across borders. At its core is the rapid development of safe drug therapies across different disciplines through the employment of genomics, targeted proteomics with predictive analytics, and other emerging drug therapies. It will use expansive patient registries and increase early access to clinical trials. The initiative is cocooned in forward-thinking drug policies that consider the specific needs of all oncology stakeholder groups both nationally and internationally.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. American Cancer Society. Global cancer facts & figures. 3rd ed. Atlanta: American Cancer Society; 2015.

    Google Scholar 

  2. FACT SHEET: Vice President Biden Delivers Cancer Moonshot Report, Announces Public and Private Sector Actions to Advance Cancer Moonshot Goals. Available at https://obamawhitehouse.archives.gov/the-press-office/2016/10/17/fact-sheet-vice-president-biden-delivers-cancer-moonshot-report.

  3. Historic National Coalition Formed to Accelerate Next Generation Immunotherapy in Cancer. Available at http://nanthealth.com/historic-national-coalition-formed-to-accelerate-next-generation-immunotherapy-in-cancer.

  4. Cancer Moonshot—National Cancer Institute. Available at https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative.

  5. NCI Formulary. Available at https://nciformulary.cancer.gov/.Partnerships: AMP and PACT—NIH Advisory Committee to the Director. Available at https://acd.od.nih.gov/documents/presentations/06092017Collins.pdf.

  6. HHS takes steps to provide more information about clinical trials to the public. Available at https://www.nih.gov/news-events/news-releases/hhs-takes-steps-provide-more-information-about-clinical-trials-public.

  7. PRECOS partners with Switzerland’s RCT to validate cancer therapies. Available at http://www.pharmatimes.com/news/precos_partners_with_switzerlands_rct_to_validate_cancer_therapies_980563.

  8. Inova and the FNIH Biomarkers Consortium Launch Public-Private Partnership to Develop Novel Imaging Methods to More Accurately Measure Cancer Response and Progression. Available at http://www.inovanewsroom.org/press-release/2017/03/inova-and-the-fnih-biomarkers-consortium-launch-public-private-partnership.

  9. FNIH. Available at https://fnih.org/about. INOVA. Available at http://www.inova.org/about-inova/index.jsp.

  10. Assumptions of Expected Benefits in Randomized Phase III Trials Evaluating Systemic Treatments for Cancer. Available at https://academic.oup.com/jnci/article/104/8/590/2517608/Assumptions-of-Expected-Benefits-in-Randomized.

  11. Biomarkers Consortium—Vol-PACT: Advanced metrics and modeling with Volumetric CT for Precision Analysis of Clinical Trial results. Available at https://fnih.org/what-we-do/biomarkers-consortium/programs/vol-pact.

  12. Hematology/Oncology (Cancer) Approvals & Safety Notifications. Available at http://wayback.archive-it.org/7993/20170111064250/, http://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm279174.htm.

  13. The State of Cancer Care in America, 2016: A Report by the American Society of Clinical Oncology. Available at https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015451/.

  14. Cancer Facts & Figures 2016. Available at https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/cancer-facts-figures-2016.html.

  15. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER cancer statistics review, 1975–2014. Bethesda, MD: National Cancer Institute. https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.

  16. DeSantis CE, Fedewa SA, Goding Sauer A, et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin. 2015;66:31–42.

    Article  Google Scholar 

  17. White Paper: FDA and Accelerating the Development of the New Pharmaceutical Therapies. Available at https://www.fda.gov/aboutfda/reportsmanualsforms/reports/ucm439082.htm.

  18. Downing NS et al. Clinical trial evidence supporting FDA approval of novel therapeutic agents, 2005–2012. J Am Med Assoc. 2014;368–77.

    Article  CAS  Google Scholar 

  19. Fleming TR. Surrogate endpoints and FDA’s accelerated approval process. Health Aff (Millwood). 2005;24(1):67–78.

    Article  Google Scholar 

  20. White Paper Prescription Drug User Fee Act (PDUFA): Adding Resources and Improving Performance in FDA Review of New Drug Applications. Available at https://www.fda.gov/forindustry/userfees/prescriptiondruguserfee/ucm119253.htm.

  21. Downing NS, Aminawung JA, Shah ND, Braunstein JB, Krumholz HM, Ross JS. N Engl J Med. 2012;366(24):2284–93. https://doi.org/10.1056/nejmsa1200223. Epub 2012 May 16. Regulatory review of novel therapeutics–comparison of three regulatory agencies.

    Article  CAS  Google Scholar 

  22. H.R.6—21st Century Cures Act. Available at https://www.congress.gov/bill/114th-congress/house-bill/6.

  23. NCI Cancer Genomics Cloud Pilots. Available at https://cbiit.nci.nih.gov/ncip/nci-cancer-genomics-cloud-pilots/access-the-cloud-pilot-platforms.

  24. Molecular Profiling and Proteogenomic Testing for the Evaluation of Malignant Tumors. Available at https://medicalpolicy.healthlink.com/medicalpolicies/policies/mp_pw_c150728.htm.

Download references

Author information

Authors and Affiliations

  1. Robert H. Lurie Comprehensive Cancer Center, Survivorship Institute, Northwestern University, Chicago, IL, 60611, USA

    Melissa Simon & June M. McKoy

  2. Feinberg School of Medicine, Northwestern University, Chicago, IL, 60611, USA

    Emmanuel Cordova

Authors
  1. Melissa Simon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Cordova
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. June M. McKoy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to June M. McKoy .

Editor information

Editors and Affiliations

  1. Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    June M. McKoy

  2. Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Dennis P. West

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Simon, M., Cordova, E., McKoy, J.M. (2019). Moonshot to Cancer Cure: Recruiting Policy to Break Down Silos. In: McKoy, J., West, D. (eds) Cancer Policy: Pharmaceutical Safety. Cancer Treatment and Research, vol 171. Springer, Cham. https://doi.org/10.1007/978-3-319-43896-2_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-43896-2_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-43894-8

  • Online ISBN: 978-3-319-43896-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation